Brian M. Stuglik, a director, sold Verastem Inc. ($VSTM) shares on the open market four times over the past year for a total of nearly $19,000, most recently on December 16, 2025. These sales rank 11,068th among insiders by value. He also sold PUMA Biotechnology Inc. ($PBYI) shares once for $27,459 on June 13, 2025, ranking 10,867th. Among 11,678 insiders with sales, the average is 8.6 million per person across about 6.4 transactions. Stuglik made no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 16, 2025 | Verastem, Inc. | $VSTM | Stuglik Brian M | Director | S | Common Stock | 592 | $9.14 | 101,147.0000 | 73,157,000 | 0.58% | 0.00% |
| Sept. 16, 2025 | Verastem, Inc. | $VSTM | Stuglik Brian M | Director | S | Common Stock | 587 | $9.99 | 101,739.0000 | 74,037,000 | 0.57% | 0.00% |
| June 16, 2025 | Verastem, Inc. | $VSTM | Stuglik Brian M | Director | S | Common Stock | 594 | $5.65 | 102,326.0000 | 54,173,000 | 0.58% | 0.00% |
| June 13, 2025 | PUMA BIOTECHNOLOGY, INC. | $PBYI | Stuglik Brian M | Director | S | Common Stock | 8100 | $3.39 | 94,958.0000 | 49,100,433 | 7.86% | 0.02% |
| June 11, 2025 | PUMA BIOTECHNOLOGY, INC. | $PBYI | Stuglik Brian M | Director | A | Common Stock | 27000 | $0.00 | 103,058.0000 | 49,100,433 | 35.50% | 0.05% |
| May 22, 2025 | Verastem, Inc. | $VSTM | Stuglik Brian M | Director | A | Stock Option (right to buy) | 12500 | $0.00 | 12,500.0000 | 54,173,000 | 9999.99% | 0.02% |
| May 22, 2025 | Verastem, Inc. | $VSTM | Stuglik Brian M | Director | A | Common Stock | 8333 | $0.00 | 102,920.0000 | 54,173,000 | 8.81% | 0.02% |
| March 17, 2025 | Verastem, Inc. | $VSTM | Stuglik Brian M | Director | S | Common Stock | 593 | $6.95 | 94,587.0000 | 35,713,000 | 0.62% | 0.00% |
| Dec. 16, 2024 | Verastem, Inc. | $VSTM | Stuglik Brian M | Director | S | Common Stock | 595 | $4.54 | 95,514.0000 | 40,258,000 | 0.62% | 0.00% |
| Dec. 19, 2024 | Verastem, Inc. | $VSTM | Stuglik Brian M | Director | S | Common Stock | 334 | $4.37 | 95,180.0000 | 40,258,000 | 0.35% | 0.00% |
| Sept. 19, 2024 | Verastem, Inc. | $VSTM | Stuglik Brian M | Director | S | Common Stock | 336 | $2.79 | 96,109.0000 | 26,861,000 | 0.35% | 0.00% |
| Sept. 16, 2024 | Verastem, Inc. | $VSTM | Stuglik Brian M | Director | S | Common Stock | 600 | $2.80 | 96,445.0000 | 26,861,000 | 0.62% | 0.00% |
| June 18, 2024 | PUMA BIOTECHNOLOGY, INC. | $PBYI | Stuglik Brian M | Director | A | Common Stock | 27000 | $0.00 | 76,058.0000 | 47,550,852 | 55.04% | 0.06% |
| June 20, 2024 | Verastem, Inc. | $VSTM | Stuglik Brian M | Director | S | Common Stock | 335 | $3.21 | 97,045.0000 | 26,832,000 | 0.34% | 0.00% |
| June 17, 2024 | Verastem, Inc. | $VSTM | Stuglik Brian M | Director | S | Common Stock | 593 | $3.49 | 89,047.0000 | 26,832,000 | 0.66% | 0.00% |
| June 18, 2024 | Verastem, Inc. | $VSTM | Stuglik Brian M | Director | A | Common Stock | 8333 | $0.00 | 97,380.0000 | 26,832,000 | 9.36% | 0.03% |
| June 18, 2024 | Verastem, Inc. | $VSTM | Stuglik Brian M | Director | A | Stock Option (right to buy) | 12500 | $0.00 | 12,500.0000 | 26,832,000 | 9999.99% | 0.05% |
| June 13, 2024 | PUMA BIOTECHNOLOGY, INC. | $PBYI | Stuglik Brian M | Director | S | Common Stock | 9900 | $3.39 | 49,058.0000 | 47,550,852 | 16.79% | 0.02% |
| March 18, 2024 | Verastem, Inc. | $VSTM | Stuglik Brian M | Director | S | Common Stock | 537 | $10.71 | 89,913.0000 | 22,054,000 | 0.59% | 0.00% |
| March 19, 2024 | Verastem, Inc. | $VSTM | Stuglik Brian M | Director | S | Common Stock | 273 | $10.38 | 89,640.0000 | 22,054,000 | 0.30% | 0.00% |
| March 11, 2024 | Verastem, Inc. | $VSTM | Stuglik Brian M | Director | A | Stock Option (right to buy) | 11865 | $0.00 | 11,865.0000 | 22,054,000 | 9999.99% | 0.05% |
| March 11, 2024 | Verastem, Inc. | $VSTM | Stuglik Brian M | Director | D | Stock Option (right to buy) | 4166 | $0.00 | 0.0000 | 22,054,000 | 100.00% | 0.02% |
| March 11, 2024 | Verastem, Inc. | $VSTM | Stuglik Brian M | Director | D | Stock Option (right to buy) | 7699 | $0.00 | 0.0000 | 22,054,000 | 100.00% | 0.03% |
| June 13, 2023 | PUMA BIOTECHNOLOGY, INC. | $PBYI | Stuglik Brian M | Director | S | Common Stock | 9900 | $3.46 | 31,958.0000 | 44,929,998 | 23.65% | 0.02% |
| June 13, 2023 | PUMA BIOTECHNOLOGY, INC. | $PBYI | Stuglik Brian M | Director | A | Common Stock | 27000 | $0.00 | 58,958.0000 | 44,929,998 | 84.49% | 0.06% |